Patient Beliefs Have a Greater Impact Than Barriers on Medication Adherence in a Community Health Center

References

1. 1.↵
   1. Osterberg L,
   2. Blaschke T

   . Adherence to medication. N Engl J Med 2005;353:487–97.

   OpenUrlCrossRefPubMedWeb of Science
2. 2.↵
   World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003. Available from: http://www.who.int/chp/knowledge/publications/adherence_report/en/index.html. Accessed March 23, 2017.
3. 3.↵
   1. Briesacher BA,
   2. Gurwitz JH,
   3. Soumerai SB

   . Patients at-risk for cost-related medication nonadherence: a review of the literature. J Gen Intern Med 2007;22:864–71.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Heisler M,
   2. Langa KM,
   3. Eby EL,
   4. et al

   . The health effects of restricting prescription medication use because of cost. Med Care 2004;42:626–34.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Hsu J,
   2. Price M,
   3. Huang J,
   4. et al

   . Unintended consequences of caps on Medicare drug benefits. N Engl J Med 2006;354:2349–59.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Vermeire E,
   2. Hearnshaw H,
   3. Van Royen P,
   4. et al

   . Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther 2001;26:331–42.

   OpenUrlCrossRefPubMedWeb of Science
7. 7.↵
   Thinking outside the pillbox: a system-wide approach to improving patient medication adherence for chronic disease. Cambridge, MA: New England Healthcare Institute; 2009.
8. 8.↵
   1. Brown MT,
   2. Bussell JK

   . Medication adherence: WHO cares? Mayo Clinic Proc 2011;86:304–14.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Ward BW,
   2. Schiller JS,
   3. Goodman RA

   . Multiple chronic conditions among US adults: a 2012 update. Prev Chronic Dis 2014;11:E62.

   OpenUrlPubMed
10. 10.↵
    1. Marcum ZA,
    2. Sevick MA,
    3. Handler SM

    . Medication nonadherence: a diagnosable and treatable medical condition. JAMA 2013;309:2105–6.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.↵
    1. Mardby A,
    2. Akerlind I,
    3. Jorgensen T

    . Beliefs about medicines and self-reported adherence among pharmacy clients. Patient Educ Couns 2007;69:158–64.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Horne R,
    2. Weinman J

    . Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Pyschosom Res 1998;47:555–67.

    OpenUrl
13. 13.↵
    1. Gatti ME,
    2. Jacobson KL,
    3. Gazmararian JA,
    4. et al

    . Relationships between beliefs about medications and adherence. Am J Health Syst Pharm 2009;66:657–64.

    OpenUrlAbstract/FREE Full Text
14. 14.↵
    1. Phatak HM,
    2. Thomas J

    . Relationships between beliefs about medications and nonadherence to prescribed chronic medications. Ann Pharmacother 2006;40:1737–42.

    OpenUrlCrossRefPubMed
15. 15.↵
    1. Gadkari AS,
    2. McHorney CA

    . Unintentional non-adherence to chronic prescription medications: how unintentional is it really? BMC Health Serv Res 2012;12:98.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Morisky DE,
    2. Alfonso A,
    3. Krousel-Wood M,
    4. et al

    . Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens 2008;10:348–54.

    OpenUrlCrossRefWeb of Science
17. 17.↵
    1. Horne R,
    2. Buick D,
    3. Fisher M,
    4. et al

    . Doubts about necessity and concerns about adverse effects: identifying the types of beliefs that are associated with non-adherence to HAART. Int J STD AIDS 2004;15:38–44.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Mahler C,
    2. Hermann K,
    3. Horne R,
    4. et al

    . Patients' beliefs about medicines in a primary care setting in Germany. J Eval Clin Pract 2012;18:409–13.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. de Oliveira-Filho AD,
    2. Morisky DE,
    3. Neves SJ,
    4. et al

    . The 8-item Morisky Medication Adherence Scale: validation of a Brazilian-Portuguese version in hypertensive adults. Res Social Adm Pharm 2014;10:554–61.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Plakas S,
    2. Mastrogiannis D,
    3. Mantzorou M,
    4. et al

    . Validation of the 8-Item Morisky Medication Adherence Scale in chronically ill ambulatory patients in rural Greece. Open J Nurs 2016;6:158–69.

    OpenUrl
21. 21.↵
    1. Moharamzad Y,
    2. Saadat H,
    3. Nakhjavan Shahraki B,
    4. et al

    . Validation of the Persian version of the 8-Item Morisky Medication Adherence Scale (MMAS-8) in Iranian hypertensive patients. Glob J Health Sci 2015;7:173–83.

    OpenUrlPubMed
22. 22.↵
    1. Krousel-Wood M,
    2. Islam T,
    3. Webber LS,
    4. et al

    . New medication adherence scale versus pharmacy fill rates in hypertensive seniors. Am J Manag Care 2009;15:59–66.

    OpenUrlPubMedWeb of Science
23. 23.↵
    1. McNutt LA,
    2. Wu C,
    3. Xue X,
    4. Hafner JP

    . Estimating the relative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 2003;157:940–3.

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    1. Gonzalez JS,
    2. Schneider HE

    . Methodological issues in the assessment of diabetes treatment adherence. Curr Diab Rep 2011;11:472–9.

    OpenUrlCrossRefPubMed